Vimarsana
Biggest News Aggregation in the World

Nasdaq Mdvl News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq Mdvl. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Mdvl Today - Breaking & Trending Today

MedAvail Announces Agreement with New Orleans-Based St. - Vimarsana News

MedAvail Announces Agreement with New Orleans-Based St.

Expands MedAvail’s presence among Federally Qualified Health Centers (FQHCs)...

MedAvail Receives Nasdaq Notification of Non-Compliance - Vimarsana News

MedAvail Receives Nasdaq Notification of Non-Compliance

PHOENIX, Nov. 17, 2023 (GLOBE NEWSWIRE) -- MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail” or the “Company”), an innovative pharmacy technology...

MedAvail (NASDAQ:MDVL) Trading Up 29.4% - Vimarsana News

MedAvail (NASDAQ:MDVL) Trading Up 29.4%

MedAvail Holdings, Inc. (NASDAQ:MDVL – Get Rating) shares were up 29.4% on Thursday . The stock traded as high as $0.39 and last traded at $0.33. Approximately 748,576 shares were traded during mid-day trading, an increase of 283% from the average daily volume of 195,333 shares. The stock had previously closed at $0.26. Wall Street […]

MedAvail (NASDAQ:MDVL) Upgraded by Zacks Investment Research to Buy - Vimarsana News

MedAvail (NASDAQ:MDVL) Upgraded by Zacks Investment Research to Buy

Zacks Investment Research upgraded shares of MedAvail (NASDAQ:MDVL – Get Rating) from a hold rating to a buy rating in a research report released on Saturday morning, Zacks.com reports. Zacks Investment Research currently has $1.50 price objective on the stock. According to Zacks, “MedAvail Holding Inc. is a technology-enabled pharmacy organization. It engages in providing […]

MedAvail (NASDAQ:MDVL) Posts Earnings Results, Misses Expectations By $0.04 EPS - Vimarsana News

MedAvail (NASDAQ:MDVL) Posts Earnings Results, Misses Expectations By $0.04 EPS

MedAvail (NASDAQ:MDVL – Get Rating) released its quarterly earnings data on Thursday. The company reported ($0.38) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.34) by ($0.04), MarketWatch Earnings reports. MedAvail had a negative net margin of 241.08% and a negative return on equity of 87.61%. During the same quarter last year, […]